Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in

  News Archive

Ubiquigent Strengthens Team to Deliver Cutting Edge Drug Discovery Services
Thursday, February 25, 2016
Ubiquigent has announced that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams to deliver an even more comprehensive range of services to the global life science research community.

Powerful Drug for Familial Amyloidosis
Thursday, February 25, 2016
The molecule has proved in preclinical trials to be up to four times more effective than the only pharmacological treatment currently available for familial transthyretin amyloidosis, a rare degenerative disease, and has already been tested in a clinical trial with patients.

Plasticell and Pierre Fabre Laboratories Sign a Partnership
Wednesday, February 24, 2016
Company has announced collaboration to identify natural stimulants of brown fat for treatment and prevention of obesity and diabetes.

HIV Modification May Put a Twist on Vaccine and Drug Design
Wednesday, February 24, 2016
Crucial HIV RNA modification called m6A influences viral replication, but wasn’t previously taken into consideration when developing anti-HIV therapies.

Rapid, Highly Sensitive Diagnostics
Tuesday, February 23, 2016
A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic tool, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions.

Secret to Promising New Cancer Drug Discovered
Tuesday, February 23, 2016
Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.

BioAgilytix Acquires IPM Biotech
Tuesday, February 23, 2016
BioAgilytix has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

Myriad Expands Collaboration with TESARO, Merck
Tuesday, February 23, 2016
Companion diagnostic portfolio to evaluate treatment response in patients with triple negative breast cancer or ovarian cancer.

Axol Appoints Paul Andrews to Scientific Advisory Board
Tuesday, February 23, 2016
Phenotypic drug discovery expert joins the stem cell disease model specialists.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 4169

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos